Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,752 | -10,536 | -16,176 | -9,527 | -4,203 |
| Depreciation Amortization | 187 | 868 | 648 | 441 | 219 |
| Accounts receivable | 3,413 | -1,907 | 2,365 | 1,418 | 1,330 |
| Accounts payable and accrued liabilities | 1,780 | -2 | 1,782 | 2,412 | 1,444 |
| Other Working Capital | 3,804 | -3,484 | 3,974 | 2,019 | 103 |
| Other Operating Activity | -4,502 | 1,700 | -3,578 | -3,925 | -3,010 |
| Operating Cash Flow | $-70 | $-13,361 | $-10,985 | $-7,162 | $-4,117 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -2 | -3 | -4 | -3 |
| Other Investing Activity | 0 | 3,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-5 | $2,998 | $-3 | $-4 | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 8,500 | N/A |
| Other Financing Activity | 0 | 10,850 | 8,500 | 0 | 0 |
| Financing Cash Flow | $N/A | $10,850 | $8,500 | $8,500 | $N/A |
| Beginning Cash Position | 6,592 | 6,105 | 6,105 | 6,105 | 6,105 |
| End Cash Position | 6,517 | 6,592 | 3,617 | 7,439 | 1,985 |
| Net Cash Flow | $-75 | $487 | $-2,488 | $1,334 | $-4,120 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70 | -13,361 | -10,985 | -7,162 | -4,117 |
| Capital Expenditure | -5 | -2 | -3 | -4 | -3 |
| Free Cash Flow | -75 | -13,363 | -10,988 | -7,166 | -4,120 |